Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant Cytokeratin 19 anticorps

Cet anticorps anti-Cytokeratin 19 est un anticorps Souris Monoclonal détectant Cytokeratin 19 dans WB, IHC, IF, FACS et StM. Adapté pour Humain.
N° du produit ABIN6939940

Aperçu rapide pour Recombinant Cytokeratin 19 anticorps (ABIN6939940)

Antigène

Voir toutes Cytokeratin 19 (KRT19) Anticorps
Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 309
  • 114
  • 85
  • 8
  • 7
  • 6
  • 5
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 162
  • 158
  • 3
  • 2
  • 1
Souris

Clonalité

  • 187
  • 139
Monoclonal

Conjugué

  • 139
  • 37
  • 19
  • 12
  • 9
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
Cet anticorp Cytokeratin 19 est non-conjugé

Application

  • 235
  • 130
  • 106
  • 82
  • 78
  • 46
  • 44
  • 41
  • 39
  • 33
  • 33
  • 32
  • 21
  • 7
  • 5
  • 5
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Staining Methods (StM)

Clone

RKRT19-799
  • Specificité

    This MAb reacts with the rod domain of human cytokeratin-19 (CK19), a polypeptide of 40 kDa. Its epitope maps between amino acid 312-335. CK19 is expressed in sweat gland, mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, and ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50 % -60 % of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow and breast cancer.

    Aucune reactivité croisée

    Furet, Rat (Rattus)

    Purification

    Purified by Protein A/G

    Immunogène

    Recombinant human full-length KRT19 protein

    Isotype

    IgG1 kappa
  • Indications d'application

    Positive Control: MCF-7, HeLa, Hep-G2 cells, Breast Cancer.

    Known Application: Flow Cytometry (0.5-1 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))

    Autre désignation

    KRT19

    Poids moléculaire

    40kDa

    ID gène

    3880

    UniProt

    P08727
Vous êtes ici:
Chat with us!